Montai Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Montai Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, focused on advancing medicines for chronic disease. It seeks to integrate technology, validated biology, and untapped human chemistry to expand the set of potential therapeutic options. The CONECTA platform supports the predictable identification of small molecules capable of engaging complex biological targets and pathways, with potential for long-term use and earlier intervention. The company has engaged in collaborations within the industry, including a 2024 partnership with Flagship Pioneering to identify targeted molecules for obesity and non-small cell lung cancer. In a recent development, Montai disclosed preclinical data on MTAI-1025, an oral NRF2 agonist, showing activity against inflammatory mechanisms in ulcerative colitis.